View in EDS

Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.

Saved in:
Bibliographic Details
Title: Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.
Authors: Yamanaka T; Kanagawa Cancer Center, Yokohama, Japan., Sohn J; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Sudo K; National Cancer Center Hospital, Tokyo, Japan., Mukai H; National Cancer Center Hospital East, Kashiwa, Japan., Yamamoto N; Chiba Cancer Center, Chiba, Japan., Chung CF; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan., Lu YS; National Taiwan University Hospital, Taipei, Taiwan., Lee KH; Seoul National University Hospital, Seoul, Republic of Korea., Lee SC; National University Cancer Institute Singapore, Singapore, Singapore., Iwasa T; Faculty of Medicine, Kindai University, Sakai, Japan., Iwata H; Aichi Cancer Center Hospital, Nagoya, Japan., Watanabe K; National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Jung KH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Tanabe Y; Toranomon Hospital, Tokyo, Japan., Kang SY; Ajou University School of Medicine, Suwon, Republic of Korea., Yasojima H; National Hospital Organization Osaka National Hospital, Osaka, Japan., Aogi K; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Tokunaga E; National Hospital Organization Kyusyu Cancer Center, Fukuoka, Japan., Sim SH; National Cancer Center, Goyang-si, Republic of Korea., Yap YS; National Cancer Centre Singapore, Singapore, Singapore., Matsumoto K; Hyogo Cancer Center, Akashi, Japan., Tseng LM; Taipei Veterans General Hospital, Taipei, Taiwan., Umeyama Y; Pfizer R&D Japan, Tokyo, Japan., Noguchi E; National Cancer Center Hospital, Tokyo, Japan., Hata T; National Cancer Center Hospital, Tokyo, Japan., Kuchiba A; National Cancer Center Hospital, Tokyo, Japan., Shibata T; National Cancer Center Hospital, Tokyo, Japan., Nakamura K; National Cancer Center Hospital, Tokyo, Japan., Fujiwara Y; National Cancer Center Hospital, Tokyo, Japan., Tamura K; National Cancer Center Hospital, Tokyo, Japan., Yonemori K; National Cancer Center Hospital, Tokyo, Japan. kyonemor@ncc.go.jp.
Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42340618
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yamanaka+T%22">Yamanaka T</searchLink>; Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Sohn+J%22">Sohn J</searchLink>; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Sudo+K%22">Sudo K</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Mukai+H%22">Mukai H</searchLink>; National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+N%22">Yamamoto N</searchLink>; Chiba Cancer Center, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Chung+CF%22">Chung CF</searchLink>; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lu+YS%22">Lu YS</searchLink>; National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+KH%22">Lee KH</searchLink>; Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SC%22">Lee SC</searchLink>; National University Cancer Institute Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Iwasa+T%22">Iwasa T</searchLink>; Faculty of Medicine, Kindai University, Sakai, Japan.<br /><searchLink fieldCode="AU" term="%22Iwata+H%22">Iwata H</searchLink>; Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Watanabe+K%22">Watanabe K</searchLink>; National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Jung+KH%22">Jung KH</searchLink>; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Tanabe+Y%22">Tanabe Y</searchLink>; Toranomon Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kang+SY%22">Kang SY</searchLink>; Ajou University School of Medicine, Suwon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yasojima+H%22">Yasojima H</searchLink>; National Hospital Organization Osaka National Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Aogi+K%22">Aogi K</searchLink>; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Tokunaga+E%22">Tokunaga E</searchLink>; National Hospital Organization Kyusyu Cancer Center, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Sim+SH%22">Sim SH</searchLink>; National Cancer Center, Goyang-si, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yap+YS%22">Yap YS</searchLink>; National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Matsumoto+K%22">Matsumoto K</searchLink>; Hyogo Cancer Center, Akashi, Japan.<br /><searchLink fieldCode="AU" term="%22Tseng+LM%22">Tseng LM</searchLink>; Taipei Veterans General Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Umeyama+Y%22">Umeyama Y</searchLink>; Pfizer R&D Japan, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Noguchi+E%22">Noguchi E</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hata+T%22">Hata T</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kuchiba+A%22">Kuchiba A</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shibata+T%22">Shibata T</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+K%22">Nakamura K</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Fujiwara+Y%22">Fujiwara Y</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tamura+K%22">Tamura K</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yonemori+K%22">Yonemori K</searchLink>; National Cancer Center Hospital, Tokyo, Japan. kyonemor@ncc.go.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100888201%22">Breast cancer (Tokyo, Japan)</searchLink> [Breast Cancer] 2026 Jun 24. <i>Date of Electronic Publication: </i>2026 Jun 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Maruzen+Co%22">Maruzen Co </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>100888201 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1880-4233 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213406868%22">13406868 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42340618
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12282-026-01865-0
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yamanaka T
      – PersonEntity:
          Name:
            NameFull: Sohn J
      – PersonEntity:
          Name:
            NameFull: Sudo K
      – PersonEntity:
          Name:
            NameFull: Mukai H
      – PersonEntity:
          Name:
            NameFull: Yamamoto N
      – PersonEntity:
          Name:
            NameFull: Chung CF
      – PersonEntity:
          Name:
            NameFull: Lu YS
      – PersonEntity:
          Name:
            NameFull: Lee KH
      – PersonEntity:
          Name:
            NameFull: Lee SC
      – PersonEntity:
          Name:
            NameFull: Iwasa T
      – PersonEntity:
          Name:
            NameFull: Iwata H
      – PersonEntity:
          Name:
            NameFull: Watanabe K
      – PersonEntity:
          Name:
            NameFull: Jung KH
      – PersonEntity:
          Name:
            NameFull: Tanabe Y
      – PersonEntity:
          Name:
            NameFull: Kang SY
      – PersonEntity:
          Name:
            NameFull: Yasojima H
      – PersonEntity:
          Name:
            NameFull: Aogi K
      – PersonEntity:
          Name:
            NameFull: Tokunaga E
      – PersonEntity:
          Name:
            NameFull: Sim SH
      – PersonEntity:
          Name:
            NameFull: Yap YS
      – PersonEntity:
          Name:
            NameFull: Matsumoto K
      – PersonEntity:
          Name:
            NameFull: Tseng LM
      – PersonEntity:
          Name:
            NameFull: Umeyama Y
      – PersonEntity:
          Name:
            NameFull: Noguchi E
      – PersonEntity:
          Name:
            NameFull: Hata T
      – PersonEntity:
          Name:
            NameFull: Kuchiba A
      – PersonEntity:
          Name:
            NameFull: Shibata T
      – PersonEntity:
          Name:
            NameFull: Nakamura K
      – PersonEntity:
          Name:
            NameFull: Fujiwara Y
      – PersonEntity:
          Name:
            NameFull: Tamura K
      – PersonEntity:
          Name:
            NameFull: Yonemori K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 06
              Text: 2026 Jun 24
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1880-4233
          Titles:
            – TitleFull: Breast cancer (Tokyo, Japan)
              Type: main
ResultId 1